Etay Ziv, MD PhD

Associate Attending
Memorial Sloan Kettering Cancer Center

Presentation(s):

• Safety and efficacy of percutaneous cryoablation for primary and metastatic intrathoracic, pleural based tumors

  Sunday, March 5, 2023
  4:21 PM – 4:30 PM

  Disclosure(s): Ethicon J&J: Research Grant Recipient (Ongoing); Novartis Pharmaceuticals Corporation: Research Grant Recipient (Ongoing)

• Genetic alterations in intrahepatic cholangiocarcinoma and response to yttrium-90 transarterial radioembolization: a case series exploring high risk genomics

  Monday, March 6, 2023
  12:00 PM – 1:00 PM

  Disclosure(s): Ethicon J&J: Research Grant Recipient (Ongoing); Novartis Pharmaceuticals Corporation: Research Grant Recipient (Ongoing)

• Long-term outcomes of PET-guided Microwave Ablation of Breast Cancer Liver Metastases

  Monday, March 6, 2023
  3:54 PM – 4:03 PM

  Disclosure(s): Ethicon J&J: Research Grant Recipient (Ongoing); Novartis Pharmaceuticals Corporation: Research Grant Recipient (Ongoing)

• Factors Associated with Improved Overall Survival for Patients Undergoing Embolization of Metastatic Melanoma

  Monday, March 6, 2023
  3:18 PM – 3:27 PM

  Disclosure(s): Ethicon J&J: Research Grant Recipient (Ongoing); Novartis Pharmaceuticals Corporation: Research Grant Recipient (Ongoing)

• NET gene mutations as prognostic biomarkers for response to TAE and TARE

  Tuesday, March 7, 2023
  9:22 AM – 9:35 AM

  Disclosure(s): Ethicon J&J: Research Grant Recipient (Ongoing); Novartis Pharmaceuticals Corporation: Research Grant Recipient (Ongoing)

• Comparison of Perioperative and Procedure Room Times Between Moderate Sedation and Monitored Anesthesia Care in Interventional Radiology

  Wednesday, March 8, 2023
  3:09 PM – 3:18 PM

  Disclosure(s): Ethicon J&J: Research Grant Recipient (Ongoing); Novartis Pharmaceuticals Corporation: Research Grant Recipient (Ongoing)